In recent, intracerebral antibodies against misfolded SOD1 have been shown to ameliorate disease phenotypes in transgenic mouse models overexpressing ALS-causing SOD1 mutations39. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.